MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Medical - Care Facilities

Healthcare
$16.99 +2.63%

+$0.40 today

Market cap
$4.78B
Beta
-3.63
P/E (TTM)
-14.2
EPS (TTM)
-$1.91
52W Low $10.65High $20.48

Volume 4.70M

Average 0.95M

MMED EBITDA Margin

EBITDA as a percentage of revenue.

MiniMed Group, Inc. Common StockNASDAQ: MMED

EBITDA Margin · Q1 FY2026 · quarter ended Jul 2026

EBITDA Margin at 9.4%

EBITDA Margin was 9.4% in Q1 FY2026. On a trailing-twelve-month basis it was 5.2%. Over 3 fiscal years it widened by 4.9 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 11 analysts of 11.4% for the fiscal year ending Apr 2027, up from 6.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
9.4%-5.1 pp QoQ
Last fiscal yearApr 2026
6.6%+2.7 pp YoY
LTMJul 2026
5.2%— YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter—+6.4 pp—
1 year+2.7 pp+4.8 pp+2.1 pp
3 years+4.9 pp+11.9 pp+7.0 pp
5 years+19.0 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
6.6%
Year-over-year change
+2.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How MMED compares with its peers on the latest reported figures

  • MMED's LTM Jul 2026 EBITDA Margin of 5.2% is the 4th highest of the 7 companies compared; the peer median is 7.3%.
  • Over three fiscal years its change of +4.9 pp compares with a peer median of +4.4 pp.
MMED Competitors Peer median
EBITDA Margin for MMED and competitors
Company Period LTM level YoY 3-year change
DXCMDexCom, Inc.LTM Jun 202631.4% +7.2 pp+9.7 pp
MDTMedtronic plcLTM Jul 202627.3% +0.0 pp-0.9 pp
PODDInsulet CorporationLTM Jun 202621.5% +4.3 pp+10.5 pp
MMEDMiniMed Group, Inc. Common StockLTM Jul 20265.2% —+4.9 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 2026-7.0% +6.7 pp-8.0 pp
BBNXBeta Bionics, Inc.LTM Mar 2026-57.6% +41.1 pp+35348.3 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-198.5% +73.8 pp-1165.0 pp
MMEDVMiniMed Group, Inc.—— ——
Peer median (excluding MMED) 7.3%+6.9 pp+4.4 pp

Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Apr 2023
FY2023
Apr 2024
FY2024
Apr 2025
FY2025
Apr 2026
Revenue2.25B2.47B2.72B3.1B
Cost of Revenue937M1.03B1.19B1.42B
Gross Profit1.31B1.44B1.53B1.68B
Gross Margin58.3%58.2%56.2%54.2%
Research & Development429M437M438M448M
Selling, General & Admin960M1.06B1.13B1.18B
Operating Expenses1.38B1.51B1.73B1.63B
Depreciation & Amortization115M129M143M156M
EBITDA39M59M107M205M
EBITDA Margin1.7%2.4%3.9%6.6%
Operating Income(69M)(69M)(202M)49M
Operating Margin-3.1%-2.8%-7.4%1.6%
Interest Income0000
Interest Expense0000
Other Income / Expenses(7M)(1M)(1M)(236M)
Income Before Tax(76M)(70M)(203M)(187M)
Pre-Tax Margin-3.4%-2.8%-7.5%-6.0%
Income Tax Expense16M38M48M128M
Net Income(96M)(112M)(250M)(331M)
Net Margin-4.3%-4.5%-9.2%-10.7%
EPS (Basic)(0.34)(0.40)(0.89)(1.29)
EPS (Diluted)(0.34)(0.40)(0.89)(1.29)
Weighted Avg Shares280.81M280.81M280.81M256.6M
Weighted Avg Shares (Diluted)280.81M280.81M280.81M256.6M

MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Intrinsic Alpha fair value

Locked

Current Price

$16.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.